Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sacubitril/Valsartan Improves Left Ventricular Function in Chronic Pressure Overload Independent of Intact Cyclic Guanosine Monophosphate-dependent Protein Kinase I Alpha Signaling

Journal of Cardiac Failure(2020)10.1016/j.cardfail.2020.04.011Source: DataRank Database

Sacubitril/Valsartan Improves Left Ventricular Function in Chronic Pressure Overload Independent of Intact Cyclic Guanosine Monophosphate-dependent Protein Kinase I Alpha Signaling is a research paper published in Journal of Cardiac Failure (2020). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.97)OA: greenTopics (60)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Daniel A. Richards ORCID,Mark Aronovitz,Gregory Martin,Suchita Pande ORCID,Iris Z. Jaffe ORCID

Live enrichment

PubMed:32464187 PMC:PMC7529795 OpenAlex:https://openalex.org/W3032014441

National Institutes of Health

Grant: R01HL131831

National Institutes of Health

Grant: 5R01HL131831-04

Novel Protein Kinase GI Substrates in Cardiac Remodeling and Blood Pressure Control

FWCI

0.97

Citation Percentile

0.8%

Citation Trend

2019

2020

2021

2022

2023

2024

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7529795

publisherhttps://api.elsevier.com/content/article/PII:S1071916419315878?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1071916419315878?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cardfail.2020.04.011

Fields of Study

Heart Failure Treatment and ManagementPhosphodiesterase function and regulationDiabetes Treatment and Management0301 basic medicine03 medical and health sciences0302 clinical medicineAminobutyratesAnimalsBiphenyl CompoundsCyclic GMP-Dependent Protein Kinase Type IDrug CombinationsGuanosine MonophosphateHeart FailureMaleMiceMice, Inbred C57BLRandom AllocationValsartanVentricular Function, Left

MeSH Terms

ValsartanAminobutyratesAnimalsBiphenyl CompoundsDrug CombinationsGuanosine MonophosphateHeart FailureMaleMice, Inbred C57BLRandom AllocationVentricular Function, LeftMiceCyclic GMP-Dependent Protein Kinase Type I

Keywords

Pressure overloadValsartanCyclic guanosine monophosphateMedicineInternal medicineEndocrinologycGMP-dependent protein kinaseHeart failureNatriuretic peptideAngiotensin IIAtrial natriuretic peptideSacubitrilReceptorBlood pressureCyclin-dependent kinase 2Nitric oxideCardiac hypertrophyMaleAminobutyratesBiphenyl CompoundsGuanosine MonophosphateVentricular Function, LeftMice, Inbred C57BLDrug CombinationsMiceRandom AllocationAnimalsCyclic GMP-Dependent Protein Kinase Type I

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being